Subscribe to our newsletter to receive the latest SafeAccess articles, straight to your inbox.sign up
Access to reproductive healthcare is changing, with women increasingly accessing healthcare services outside of facility settings.
Evidence shows that a pharmacy is often a first port-of-call for many women in low and middle-income countries and medical abortions via this route can be just as safe as in-facility services, if women are provided with a quality product, sufficient guidance on how to self-administer the product, and contact details for onward facility-based support, if needed.
Meanwhile, data from MSI Reproductive Choice's telemedicine programme in the UK shows that home-based services are just as safe and effective as in-facility care, can reduce average wait times and are preferred by many clients.
In this short explainer video, we share the evidence behind how we can support women to self-manage their medical abortion, either via a home-based telemedicine service or via a pharmacy, safely.
A global systematic review of telemedicine care from the World Health Organization and others found similar results: safety, effectiveness and client satisfaction in telemedicine services are comparable with outcomes of in-person services.